Dendritic cell subsets biology and application in cancer immunotherapy.

Autor: Mofazzal-Jahromi, Ma¹, Moazzeni, Sm¹ moazzeni@modares.ac.ir

Publikováno v: Feyz Journal of Kashan University of Medical Sciences. 2013, Vol. 17 Issue 1, p100-113. 14p.

Antihyperglycemic activity of phenolics from Pterocarpus marsupium

Autor: Anil B. Ray, Muthiah Ramanathan, Chansouria Jp, Jahromi Ma, M. Manickam

Publikováno v: Journal of natural products. 60(6)

Glucose levels in rats with hyperglycemia induced by streptozotocin were determined after i.p. administration of marsupsin (1), pterosupin (2), and pterostilbene (3), three important phenolic constituents of the heartwood of Pterocarpus marsupium. Ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3af9dd1955eaa9ccc3d56f475837385
https://pubmed.ncbi.nlm.nih.gov/9214733

Withametelin inhibits TGF-β induced Epithelial-to-Mesenchymal Transition and Programmed-Death Ligand-1 expression in vitro .

Autor: Fathima A; Cell Signaling Laboratory, Department of Biological Sciences, Birla Institute of Technology & Science, Hyderabad, India., Farboodniay Jahromi MA; Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Begum SA; Department of Pharmacy, Birla Institute of Technology & Science, Hyderabad, India., Jamma T; Cell Signaling Laboratory, Department of Biological Sciences, Birla Institute of Technology & Science, Hyderabad, India.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jul 15; Vol. 14, pp. 1435516. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).

Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET ^® CC-96191.

Autor: Lunn-Halbert MC; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Laszlo GS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Erraiss S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Orr MT; Immuno-Oncology Cellular Therapy Thematic Research Center, Bristol Myers Squibb, Seattle, WA 98109, USA., Jessup HK; Immuno-Oncology Cellular Therapy Thematic Research Center, Bristol Myers Squibb, Seattle, WA 98109, USA., Thomas HJ; Immuno-Oncology Cellular Therapy Thematic Research Center, Bristol Myers Squibb, Seattle, WA 98109, USA., Chan H; Bristol Myers Squibb, San Diego, CA 92121, USA., Jahromi MA; Bristol Myers Squibb, San Diego, CA 92121, USA., Lloyd J; Bristol Myers Squibb, San Diego, CA 92121, USA., Cheung AF; Dragonfly Therapeutics, Waltham, MA 02451, USA., Chang GP; Dragonfly Therapeutics, Waltham, MA 02451, USA., Dichwalkar T; Dragonfly Therapeutics, Waltham, MA 02451, USA., Fallon D; Dragonfly Therapeutics, Waltham, MA 02451, USA., Grinberg A; Dragonfly Therapeutics, Waltham, MA 02451, USA., Rodríguez-Arbolí E; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, 41013 Seville, Spain., Lim SYT; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kehret AR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Huo J; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Cole FM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Scharffenberger SC; Molecular Medicine and Mechanisms of Disease (M3D) Ph.D. Program, University of Washington, Seattle, WA 98195, USA., Walter RB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA 98195, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Publikováno v: Cancers [Cancers (Basel)] 2024 Feb 22; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 22.

Evaluation of the Therapeutic Effect of Quadrivalent Human Papillomavirus (HPV) Vaccination on Cervical Intraepithelial Neoplasia Lesions.

Autor: Shiravani Z; Gynecology Oncology Division, Department of Obstetrics & Gynecology, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran.; Maternal-Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Nazari Z; Gynecology Department, Mazandaran University of Medical Sciences, Emam Khomeini Hospital, Kasra Medical Building, 2nd Floor, Sari, Iran., Yazdani F; Gynecology Oncology Division, Department of Obstetrics & Gynecology, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran., Najib FS; Infertility Research Center, Department of Obstetrics and Gynecology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran., Jahromi MA; Pathology Department, School of Medicine, Maternal-Fetal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Momtahan M; Gynecology Oncology Division, Department of Obstetrics & Gynecology, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran., Pourseyed S; Gynecology Oncology Division, Department of Obstetrics & Gynecology, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran., Moradialamdarloo S; Maternal-Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Tafti MH; Fellowship of Gynecology Oncology, Department of Obstetrics & Gynecology, School of Medicine, Shahidsadoughi University of Medical Science, Yazd, Iran.

Publikováno v: Indian journal of surgical oncology [Indian J Surg Oncol] 2023 Jun; Vol. 14 (2), pp. 504-509. Date of Electronic Publication: 2022 Oct 01.